Mycardis, tablets 40 mg 28 pcs

Name: Mycardis, tablets 40 mg 28 pcs
SKU: 23167
Availability: InStock

€33.21

EAN: 9006968010335 SKU: 23167 Categories: Cardiovascular, High pressure, Medicine

Description

– arterial hypertension;
– reduction of cardiovascular morbidity and mortality in patients aged 55 years and older with a high risk of cardiovascular disease.

Active ingredient

Telmisartan

Composition

Tablets are white or almost white, oblong, engraved “52H” on one side and the company symbol on the other side.

1 tablet

How to take, the dosage

The drug is prescribed orally, regardless of meals.

Interaction

Telmisartan may increase the hypotensive effect of other antihypertensive agents. Other interactions of clinical relevance have not been identified.

Special Instructions

In some patients, renal function (including acute renal failure) is impaired due to suppression of the RAAS, especially when using a combination of agents acting on this system. Therefore, therapy accompanied by such dual RAAS blockade (e.g., when adding ACE inhibitors or direct renin inhibitor aliskiren to angiotensin II receptor antagonist blockers) should be performed strictly individually and with careful monitoring of renal function (including periodic monitoring of serum potassium and creatinine concentration).

Contraindications

– Obstructive biliary tract diseases;
– severe liver function abnormalities (class C on the Child-Pugh scale);
– simultaneous use with aliskiren in patients with diabetes or renal insufficiency (FFR <60 ml/min/1.Fructose intolerance, glucose/galactose malabsorption syndrome or sucrose/isomaltase deficiency;
– Age < 18 years (efficacy and safety have not been determined);
– Pregnancy;
– Breast-feeding period;
– Hypersensitivity to the active substance or excipients of the preparation.
– bilateral renal artery stenosis or stenosis of the artery of the only kidney;
– liver and/or kidney function disorders;
– Decrease of the circulatory volume due to the preceding diuretic therapy, salt restriction, diarrhea or vomiting;
– hyponatremia;
– hyperkalemia;
– conditions after kidney transplantation (no experience of use);
– chronic heart failure;
– aortic and mitral valve stenosis;
– idiopathic hypertrophic subaortic stenosis;
– primary aldosteronism (effectiveness and safety not established).

Side effects

The observed cases of side effects did not correlate with the gender, age, or race of the patients.

Overdose

No cases of overdose have been identified.

Similarities

Telsartan, Telzap, Telmista, Telpres, Telmisartan

Additional information

Weight	0.230 kg
Shelf life	4 years.
Conditions of storage	The drug should be kept out of reach of children, protected from moisture at a temperature not exceeding 30°C.
Manufacturer	Boehringer Ingelheim Pharma GmbH & Co.
Medication form	pills
Brand	#Н/Д